Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

IN BRIEF: Open Orphan To Lead Challenge Agent Development Consortium

19th Nov 2020 21:18

Open Orphan PLC - contract research organisation & pharmaceutical services company - Subsidiary hVIVO chosen to lead consortium on behalf of international researcher network HIC-Vac, and the Wellcome Trust to develop international standards on the manufacture of human challenge agents for use in controlled human infection studies.

Current stock price: 23.21 pence

Year-to-date change: up sharply from 4.55p

By Dayo Laniyan; [email protected]

Copyright 2020 Alliance News Limited. All Rights Reserved.


Related Shares:

ORPH.L
FTSE 100 Latest
Value8,809.74
Change53.53